DUET-01: A first-in-human, phase 1/2 study of BOXR1030 in patients with advanced glypican-3-positive solid tumors

Category Primary study
JournalJournal of Clinical Oncology
Year 2024
This article has no abstract
Epistemonikos ID: 146a2c39fd097854c68c6c78fc15b9e8f680b9c3
First added on: Feb 18, 2025